SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 02:25:26 2024-06-14 pm EDT | ||
| 2.193 EUR | +0.50% |
|
| Current month | -0.50% | ||
| 1 month | +16.65% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 2.193 | +0.50% |
| 24-06-13 | 2.182 | +6.34% |
| 24-06-12 | 2.052 | -0.92% |
| 24-06-11 | 2.071 | -1.47% |
| 24-06-10 | 2.102 | -4.50% |
Real-time BOERSE MUENCHEN
Last update June 14, 2024 at 02:25 pm EDT
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GQ00EE |
| ISIN | DE000GQ00EE2 |
| Date issued | 2023-07-25 |
| Strike | 64.96 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.14 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.304 € |
|---|---|
| Lowest since issue | 0.228 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
53.19
USD
Spread / Average Target
+29.11%
- Stock Market
- Certificates
- Certificat
